Brief: Dawnrays Pharmaceutical Posts FY Profit Attributable RMB326.0 Mln
22/03/2024 15:36
March 22 (Reuters) - Dawnrays Pharmaceutical (Holdings)
Ltd 2348.HK :
* FY PROFIT ATTRIBUTABLE RMB326.0 MILLION VERSUS RMB358.1
MILLION
* FY REVENUE RMB1.15 BILLION VERSUS RMB1.28 BILLION
* RECOMMENDS PAYMENT OF FINAL DIVIDEND OF HK$0.065 PER SHARE
Further company coverage: 2348.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dawnrays Pharmaceutical (Holdings)
See all newsBrief: Dawnrays Pharmaceutical Says Suzhou Dawnrays Commits To Invest Up To RMB100 Mln In Partnership
Brief: Dawnrays Pharmaceutical (Holdings) Final Dividend Of Hk$0.048 Per Share
Brief: Dawnrays Pharmaceutical Reports HY Net Income Attributable Of RMB104.6 MLN
Brief: Dawnrays Pharmaceutical (Holdings) Posts FY Profit Attributable Of Rmb564.9 Million
Brief: Dawnrays Pharmaceutical (Holdings) Appoints Yu Liwei To Act As CEO